<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02268162</url>
  </required_header>
  <id_info>
    <org_study_id>lungcancer diagnosis</org_study_id>
    <secondary_id>201402024</secondary_id>
    <nct_id>NCT02268162</nct_id>
  </id_info>
  <brief_title>Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination</brief_title>
  <official_title>Prospective Multicenter Randomized Control Study on Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinqiao Hospital of Chongqing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China Meitan General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Micro-Tech (Nanjing) Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the value of different bronchoscopy combination for diagnosing
      peripheral pulmonary lesions suspected to be cancer. One-third of participants will receive
      routine bronchoscopy, while one-third of participants will receive bronchoscopy combined with
      a guiding equipment and the other one-third of participants will receive bronchoscopy
      combined with two or more guiding equipments. These guiding equipments include virtual
      bronchoscopic navigation(VBN), endobronchial ultrasonography with a guide sheath(EBUS-GS) and
      fluoroscopy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic yield for pulmonary peripheral lesions</measure>
    <time_frame>7 days</time_frame>
    <description>The diagnostic yield for individuals with pulmonary peripheral lesions examined by bronchoscopy with or without guiding equipments</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of operation time using bronchoscopy or bronchoscopy combination</measure>
    <time_frame>30 minutes</time_frame>
    <description>The operation time using bronchoscopy or bronchoscopy combination to examine a participant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay in hospital</measure>
    <time_frame>7 days</time_frame>
    <description>length of stay in hospital for a participant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalization costs</measure>
    <time_frame>7 days</time_frame>
    <description>the hospitalization costs for a participant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with adverse events or serious adverse events</measure>
    <time_frame>2 weeks</time_frame>
    <description>Number of participants with any adverse events or serious adverse events</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">3228</enrollment>
  <condition>Lung Neoplasms</condition>
  <condition>Early Diagnosis</condition>
  <condition>Bronchoscopy</condition>
  <arm_group>
    <arm_group_label>Routine Bronchoscopy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the group will receive routine bronchoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine Bronchoscopy with a guiding equipment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the group will receive routine bronchoscopy combined with a guiding equipment. These guiding equipments include virtual bronchoscopic navigation(VBN), endobronchial ultrasonography with a guide sheath(EBUS-GS) and fluoroscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine Bronchoscopy with two or more guiding equipments</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the group will receive routine bronchoscopy combined with two or more guiding equipments. These guiding equipments include virtual bronchoscopic navigation(VBN), endobronchial ultrasonography with a guide sheath(EBUS-GS) and fluoroscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>guiding equipments</intervention_name>
    <description>The guiding equipments including VBN, EBUS-GS and fluoroscopy guide a bronchoscope along the bronchial route to a peripheral pulmonary lesion.</description>
    <arm_group_label>Routine Bronchoscopy with a guiding equipment</arm_group_label>
    <arm_group_label>Routine Bronchoscopy with two or more guiding equipments</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible subjects are adults with solitary peripheral pulmonary lesions (mean
             diameter, ≤30mm and &gt;8mm from axial CT images) suspected to be cancer but were not
             pathologically confirmed.

        Exclusion Criteria:

          -  Patient has dysrhythmia or cardiovascular disease that poses a risk during exercise.

          -  Patient has uncontrollable hypertension (SBP &gt; 180mmHg).

          -  Patient has severe organ dysfunction (shock, severe hepatic and renal dysfunction,
             massive hemorrhage of upper gastrointestine, diffuse intravascular coagulation(DIC)
             and massive hemoptysis,etc).

          -  Patient has blood coagulation disorders (PT&gt;2 times the upper limit of normal(ULN) or
             Platelet(PLT)&lt;50000/ul）.

          -  Patient has severe dyspnea.

          -  Patient is allergic to local anesthetic.

          -  Patient is unable to provide informed consent.

          -  Patient is not an appropriate candidate for of is unable to tolerate flexible
             bronchoscopy procedures.

          -  Patient has any disease or condition that interferes with completion of initial or
             follow-up assessments of the effectiveness endpoints.

          -  Patient has demonstrated unwillingness or inability to complete screening or baseline
             data collection procedures.

          -  Patient participated in a study of an investigational drug or device within the past
             30 days prior to participation in this study, or is currently participating in another
             clinical study.

          -  Female patient of childbearing potential has a positive result from a pregnancy test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faguang Jin, MD &amp; PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tang-Du Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lei Pan, MD &amp; PhD</last_name>
    <phone>86-29-84778526</phone>
    <email>panlei@fmmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yandong Nan, MD</last_name>
    <phone>86-29-84717533</phone>
    <email>nanyandong2008@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei Pan, Ph.D, MD</last_name>
      <phone>86-29-84778526</phone>
      <email>panlei@fmmu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Yandong Nan, MD</last_name>
      <phone>86-29-84717533</phone>
      <email>nanyandong@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Lei Pan, Ph.D, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Asano F, Shinagawa N, Ishida T, Shindoh J, Anzai M, Tsuzuku A, Oizumi S, Morita S. Virtual bronchoscopic navigation combined with ultrathin bronchoscopy. A randomized clinical trial. Am J Respir Crit Care Med. 2013 Aug 1;188(3):327-33. doi: 10.1164/rccm.201211-2104OC.</citation>
    <PMID>23600452</PMID>
  </reference>
  <reference>
    <citation>Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, Wiener RS. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):e93S-e120S. doi: 10.1378/chest.12-2351. Review.</citation>
    <PMID>23649456</PMID>
  </reference>
  <reference>
    <citation>Shinohara S, Hanagiri T, Takenaka M, Chikaishi Y, Oka S, Shimokawa H, Nakagawa M, Uramoto H, So T, Aoki T, Tanaka F. Evaluation of undiagnosed solitary lung nodules according to the probability of malignancy in the American College of Chest Physicians (ACCP) evidence-based clinical practice guidelines. Radiol Oncol. 2014 Jan 22;48(1):50-5. doi: 10.2478/raon-2013-0064. eCollection 2014 Mar.</citation>
    <PMID>24587779</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2014</study_first_submitted>
  <study_first_submitted_qc>October 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2014</study_first_posted>
  <last_update_submitted>November 13, 2015</last_update_submitted>
  <last_update_submitted_qc>November 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lung Neoplasms</keyword>
  <keyword>Bronchoscopy</keyword>
  <keyword>Virtual Bronchoscopic Navigation(VBN)</keyword>
  <keyword>Fluoroscopy</keyword>
  <keyword>Endobronchial Ultrasonography with a Guide Sheath(EBUS-GS)</keyword>
  <keyword>Diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

